Atlas Trials

Relapsed Ovarian Cancer

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed Ovarian Cancer

RecordFirmDate
OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC (NCT04713514)ARCAGY/ GINECO GROUP2021-08-05
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer (NCT04999605)Akeso2021-06-24
A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients (NCT04517357)Jiangsu HengRui Medicine Co., Ltd.2020-10-16
Reprab Study: PLD + Trabectedin Rechallenge (NCT04887961)Fondazione Policlinico Universitario Agostino Gemelli IRCCS2020-10-01
Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy (NCT03534453)AstraZeneca2018-05-29
Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients (NCT02825420)PharmaMar2015-07-28
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy (NCT01874353)AstraZeneca2013-09-03

Track Relapsed Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.